Fig. 4: RAB14-promoted epithelial‑mesenchymal transition (EMT) in bladder cancer.

A Immunofluorescence staining of E-cadherin in shRAB14 T24 cells and control. B Immunofluorescence staining of Vimentin in shRAB14 T24 cells and control. C Immunofluorescence analysis of cellular morphology in shRAB14 T24 cells and control. D Western blot of E-cadherin, N-cadherin and Vimentin. E Consensus clustering cumulative distribution function (CDF). F Relative change in the area under the CDF curve. G Consensus clustering matrix of two clusters. H Heatmap of two different clusters (C1, C2) based on RAB14-related EMT gene expression. I Principal components analysis (PCA) of two different clusters (C1, C2) from TCGA BLCA samples for k = 2. J Kaplan–Meier curve of overall survival of patients with BCLA in two clusters. *P < 0.05, **P < 0.001.